MoneyWorks4Me

Gufic Biosciences - Quaterly Results

09 Feb 2022 Evaluate
The total revenue for the quarter ended December 2021 remained nearly unchanged at Rs. 1720.65 millions.The company has announced a 36.01% increase in its profits to Rs . 210.34  millions for the  quarter ended December 2021 compared to Rs. 154.65 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended December 2021 rose to 342.49 millions as compared to 274.55 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1720.65 1665.57 3.31 6169.62 3557.70 73.42 4876.99 3788.37 28.74
Other Income 15.30 0.33 4536.36 30.63 30.77 -0.45 37.33 57.90 -35.53
PBIDT 342.49 274.55 24.75 1172.59 632.50 85.39 876.52 579.06 51.37
Interest 10.32 37.79 -72.69 37.90 107.61 -64.78 136.33 139.15 -2.03
PBDT 332.17 236.76 40.30 1134.69 524.89 116.18 740.19 439.91 68.26
Depreciation 44.84 32.23 39.13 128.07 118.26 8.30 163.08 138.65 17.62
PBT 287.33 204.53 40.48 1006.62 406.63 147.55 577.11 301.26 91.57
TAX 76.99 49.88 54.35 250.86 93.02 169.68 134.80 74.38 81.23
Deferred Tax 4.29 2.15 99.53 -4.14 1.39 -397.84 20.11 8.85 127.23
PAT 210.34 154.65 36.01 755.76 313.61 140.99 442.31 226.88 94.95
Equity 96.95 96.95 0.00 96.95 96.95 0.00 96.95 77.83 24.57
PBIDTM(%) 19.90 16.48 20.75 19.01 17.78 6.91 17.97 15.29 17.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..